Literature DB >> 24355447

Reduced specialist time with direct computed tomography for suspected lung cancer in primary care.

Louise Mahncke Guldbrandt1, Morten Fenger-Grøn, Birgitte Holst Folkersen, Torben Riis Rasmussen, Peter Vedsted.   

Abstract

INTRODUCTION: Lung cancer (LC) is the most common cause of cancer death in Denmark, and triaging patients through fast-track diagnostic pathways is recommended to improve patient outcome. Data on the most efficient triage organisation of such pathways are limited. The aim of this study was to test a strategy of a straight-to-test model for patients referred to the fast-track pathway. Outcomes were number of computed tomographies (CT) performed, use of specialist time and staff acceptability.
MATERIAL AND METHODS: We performed a randomised controlled study enrolling 493 patients who were referred from general practice to fast-track LC evaluation (1 January-1 December 2012). Half of the patients were randomly assigned to the intervention and went straight to a chest CT before chest-physician evaluation. Time was measured for patients at random days. Acceptability was examined in a focus group interview.
RESULTS: In the intervention group, 95.5% of patients had a CT performed compared with 97.2% in the control group. There was no difference in the number of CTs between the groups (risk difference (RD) = 1.3% (95% confidence interval (CI): 4.4-2.0; p = 0.454)). In the intervention group, chest-physician time was 13.3 min. (min.-max.: 7.7-19.5 min.) lower per referred patient than in the control group.
CONCLUSION: Giving general practitioners direct access to a CT did not change the number of CTs performed and significantly reduced chest-physician time per patient. In addition, the strategy was associated with high levels of staff acceptability. FUNDING: The project was supported by the Danish Cancer Research Foundation, the Danish Cancer Society and the Novo Nordisk Foundation. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01779726.

Entities:  

Mesh:

Year:  2013        PMID: 24355447

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  7 in total

1.  New NICE guidance on diagnosing cancer in general practice.

Authors:  Jon Emery; Peter Vedsted
Journal:  Br J Gen Pract       Date:  2015-09       Impact factor: 5.386

2.  The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability.

Authors:  Mads Lind Ingeman; Morten Bondo Christensen; Flemming Bro; Søren T Knudsen; Peter Vedsted
Journal:  BMC Cancer       Date:  2015-05-20       Impact factor: 4.430

3.  A differentiated approach to referrals from general practice to support early cancer diagnosis - the Danish three-legged strategy.

Authors:  P Vedsted; F Olesen
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

4.  Implementing direct access to low-dose computed tomography in general practice--method, adaption and outcome.

Authors:  Louise Mahncke Guldbrandt; Torben Riis Rasmussen; Finn Rasmussen; Peter Vedsted
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

5.  Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma.

Authors:  Heidi Buvarp Dyrop; Peter Vedsted; Mathias Rædkjær; Akmal Safwat; Johnny Keller
Journal:  Acta Orthop       Date:  2017-01-12       Impact factor: 3.717

6.  Use of Healthcare Services Two Years before Diagnosis in Danish Sarcoma Patients, 2000-2013.

Authors:  Mathias Rædkjær; Katja Maretty-Kongstad; Thomas Baad-Hansen; Akmal Safwat; Michael M Petersen; Johnny Keller; Peter Vedsted
Journal:  Sarcoma       Date:  2019-05-07

7.  Diagnostic property of direct referral from general practitioners to contrast-enhanced thoracoabdominal CT in patients with serious but non-specific symptoms or signs of cancer: a retrospective cohort study on cancer prevalence after 12 months.

Authors:  Marie Møller; Bue Juvik; Stine Chabert Olesen; Hanne Sandstrøm; Erling Laxafoss; Simon Bertram Reuter; Uffe Bodtger
Journal:  BMJ Open       Date:  2019-12-31       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.